Company intelligence / Profile preview

ASBIS

Ownership: Private
Employees: ~2200
Development stage: Other

Overview

ASBIS is a leading value-added distributor, developer, and supplier of IT, IoT products, solutions, and services across Europe, the Middle East, and Africa. In recent years it has diversified by investing in early-stage biotechnology startups focused on oncology therapeutics, regenerative medicine biomaterials (collagen), rapid diagnostics devices for health/environmental testing—including COVID-19—and dermaceuticals for cancer patients. These investments are housed within its High-Tech Cluster HUB in Cyprus.

Industry: Investors

Partnerships

No major pharma partnerships reported at the group level. Strategic partnerships exist between invested startups and research institutions or hospitals.

Beyond the preview

Go deeper on ASBIS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASBIS.

Explore the full profile